Q-omics provides the consensus-scored RBMY2NP profile across patient tissues and cancer cell-line models. RBMY2NP expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, RBMY2NP RNA expression shows 2,566 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight ESCA, and LUSC as cancer lineages where RBMY2NP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.